Workflow
Initial Public Offering
icon
Search documents
Citi to turn to more minority investors after Banamex stake sale
Reuters· 2025-09-25 21:49
Core Viewpoint - Citigroup is seeking additional minority investors for its Mexican retail unit, Banamex, prior to a potential initial public offering (IPO) [1] Group 1 - Citigroup's executives announced the strategy to attract more minority investors for Banamex [1] - The move is part of the preparations for a potential IPO of the retail unit [1]
Megan Holdings Limited Announces Pricing of $5 Million Initial Public Offering
Globenewswire· 2025-09-25 20:55
Group 1 - Megan Holdings Limited, a Malaysia-based company, is engaged in the development, construction, and maintenance of aquaculture farms and related works [6] - The company has priced its initial public offering (IPO) at US$4.00 per ordinary share, offering 1,250,000 shares, with an additional option for underwriters to purchase up to 187,500 shares [1][2] - The IPO is expected to generate gross proceeds of US$5 million, which will be allocated for sales and marketing, expansion through mergers and acquisitions, development of a "Smart Farming System," and general working capital [2] Group 2 - The offering is being conducted on a firm commitment basis, with D. Boral Capital LLC acting as the sole book-running manager [3] - The registration statement for the offering was filed with the U.S. Securities and Exchange Commission (SEC) and declared effective on September 22, 2025 [4] Group 3 - Since its inception in 2020, the company has positioned itself as a trusted provider of shrimp farm maintenance services in Malaysia, including the development of a shrimp hatchery center and a 111-acre shrimp farm [6]
X @Bloomberg
Bloomberg· 2025-09-25 20:14
The list of companies to tumble after a sizable US initial public offering has a new headline member: StubHub https://t.co/xH5b6TyOo0 ...
HCI Group Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Subsidiary, Exzeo Group, Inc.
Globenewswire· 2025-09-25 13:15
Core Viewpoint - HCI Group, Inc. has announced that its subsidiary, Exzeo Group, Inc., has filed a registration statement for a proposed initial public offering (IPO) of its common stock, with details on the number of shares and price range yet to be determined [1] Group 1: IPO Details - The offering is subject to market conditions, and there is no assurance regarding the completion, size, or terms of the offering [1] - Truist Securities, Citizens Capital Markets, and William Blair are acting as joint book-running managers, while Fifth Third Securities is a co-manager for the offering [2] Group 2: Registration Statement - A registration statement on Form S-1 has been filed with the SEC but has not yet become effective, meaning the securities cannot be sold or offers accepted until it is effective [4] Group 3: Company Overview - HCI Group is a holding company with two operating units: one includes insurance companies and a reinsurance company, while the other, Exzeo Group, focuses on insurance technology using advanced algorithms and data analytics [5] - HCI Group's common shares are traded on the NYSE under the ticker symbol "HCI" and are included in the Russell 2000 and S&P SmallCap 600 Index [6]
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
Globenewswire· 2025-09-25 10:43
Company Overview - Drugs Made In America Acquisition II Corp. is a blank check company incorporated in the Cayman Islands, aimed at effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses [5] - The company has not selected any specific business combination target and has not engaged in substantive discussions with any potential targets [5] - The company intends to focus its search for businesses in the pharmaceutical industry, aiming to mitigate risks in the U.S. medical supply chain by investing in companies that reduce reliance on concentrated geographic production of pharmaceuticals [5] Initial Public Offering (IPO) Details - The company announced the pricing of its initial public offering of 50,000,000 units at $10.00 per unit, with units expected to trade on Nasdaq under the ticker symbol "DMIIU" starting September 25, 2025 [1] - Each unit consists of one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an initial business combination [1] - The offering is expected to close on September 26, 2025, subject to customary closing conditions [1] - Underwriters have a 45-day option to purchase up to an additional 7,500,000 units to cover over-allotments [1] Legal and Regulatory Information - A registration statement on Form S-1 relating to these securities has been filed with the SEC and was declared effective on September 24, 2025 [3] - The offering is being made only by means of a prospectus, which can be obtained from Cantor Fitzgerald & Co. or the SEC website [3]
Emmis Acquisition Corp. Announces the Pricing of $100,000,000 Initial Public Offering
Globenewswire· 2025-09-25 00:20
Company Overview - Emmis Acquisition Corp. is a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [3] - The company may pursue acquisition opportunities across various industries, focusing on industrial and business services, manufacturing, transportation, distribution, and technology sectors [3] Initial Public Offering (IPO) Details - The company announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit, with trading expected to begin on September 25, 2025, under the ticker symbol "EMISU" [2] - Each unit consists of one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share upon the consummation of an initial business combination [2] - An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering, which is expected to close on September 26, 2025, subject to customary closing conditions [2] - The underwriters have been granted a 45-day option to purchase up to an additional 1,500,000 units at the initial public offering price to cover over-allotments [2] Management Team - The management team is led by Peter Goldstein, Chief Executive Officer and Director, and David Lowenstein, Chief Financial Officer and Director [4] - The Board includes Anna C Mallon, Low Koon Poh, and Seth Farbman [4] - I-Bankers Securities, Inc. and IB Capital LLC are acting as book-running managers for the offering [4]
X @Bloomberg
Bloomberg· 2025-09-24 02:04
Zijin Gold has delayed its $3.2 billion listing after Super Typhoon Ragasa slammed Hong Kong, bringing the city to a standstill and disrupting the company’s ability to take orders for its initial public offering https://t.co/IB3nf7yB2z ...
X @Bloomberg
Bloomberg· 2025-09-23 08:31
Hong Kong exchange rules require companies to push back the entire IPO process by at least one business day if a No. 8 typhoon signal or above is in place between 9 a.m. and noon on the final day for mom-and-pop investors to order shares https://t.co/YvJaS3yhp4 ...
Platinum Analytics Cayman Limited Announces Closing of Its Initial Public Offering and Full Exercise of Over Allotment
Globenewswire· 2025-09-23 01:00
Company Overview - Platinum Analytics Cayman Limited is a software developer specializing in FX trading software, data analytics, and technology solutions for financial institutions, with a strategic focus on Asia and emerging markets [6][7] - The company was established in 2017 in Singapore and operates through its wholly-owned subsidiary, Platinum Analytics Singapore Pte. Ltd. [6] Initial Public Offering (IPO) Details - The company closed its initial public offering of 2,300,000 Class A ordinary shares at a public offering price of $4.00 per share, resulting in gross proceeds of $9,200,000 [1] - The offering included the underwriters' full exercise of their over-allotment option and commenced trading on the Nasdaq Capital Market under the ticker symbol "PLTS" on September 19, 2025 [1][2] Use of Proceeds - The company plans to allocate approximately $3.3 million (40% of net proceeds) for research and development, $2.4 million (30%) for expanding its marketing and sales team, and $2.4 million (30%) for IT facilities and financial licenses [3] Regulatory Filings - A registration statement on Form F-1 was filed with the U.S. Securities and Exchange Commission (SEC) and was declared effective on September 18, 2025 [4]
X @Bloomberg
Bloomberg· 2025-09-22 19:08
Investment bankers welcome the rebound in US IPOs, but it’s too late to stop the long-term decline in public companies amid booming private markets https://t.co/aTCeErukEI ...